Abbott expects an adjusted profit of $5.05 to $5.25 per share for 2025, compared with analysts' average profit expectation of $5.16. On an adjusted basis, the company reported a quarterly profit of $1.34 per share, in line with analysts' average expectations, according to estimates compiled by LSEG.

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed strength in medical devices, sending its shares down more than 2% in premarket trading.

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street estimates, along with weak fourth-quarter sales in segments other than medical devices, sending its shares down 1% in p